MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
29.04
-2.93 (-9.16%)
At close: Apr 28, 2026, 4:00 PM EDT
29.30
+0.26 (0.90%)
After-hours: Apr 28, 2026, 5:35 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.38 billion as of April 28, 2026. Its market cap has increased by 559.18% in one year.
Market Cap
1.38B
Enterprise Value
1.01B
1-Year Change
559.18%
Ranking
Category
Stock Price
$29.04
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.38B, an increase of 171.05%. That is a compound annual growth rate of 85.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.52B | 7.39% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.60B |
| Oculis Holding AG | 1.59B |
| Immatics | 1.55B |
| Bicara Therapeutics | 1.52B |
| Damora Therapeutics | 1.52B |
| Biohaven | 1.51B |
| Agios Pharmaceuticals | 1.50B |
| Immunocore Holdings | 1.50B |